Arch. Endocrinol. Metab. 2017;61(5):411-413
Is the 18F-FDG PET/CT the definite resource to detect the recurrence on high-risk thyroid cancer patients?
DOI: 10.1590/2359-3997000000300
DOI: 10.1590/2359-3997000000300
Flow diagram of patient exclusion criteria for SNMTC and FNMTC groups.
Buchpiguel CA. Is the 18F-FDG PET/CT the definite resource to detect the recurrence on high-risk thyroid cancer patients?. Arch. Endocrinol. Metab. 2017;61(5):411-3.
Buchpiguel, Carlos Alberto. Is the 18F-FDG PET/CT the definite resource to detect the recurrence on high-risk thyroid cancer patients?. Arch. Endocrinol. Metab., v. 61, n. 5, p. 411-413, Sep. 2017.
Buchpiguel, C. A. (2017). Is the 18F-FDG PET/CT the definite resource to detect the recurrence on high-risk thyroid cancer patients?. Arch. Endocrinol. Metab., 61(5), 411-413.
Buchpiguel, Carlos Alberto. Is the 18F-FDG PET/CT the definite resource to detect the recurrence on high-risk thyroid cancer patients?. Arch. Endocrinol. Metab. [online]. 2017, vol. 61, n. 5, [cited 2026-03-07], pp.411-413. Available from: <https://www.aem-sbem.com/article/is-the-18f-fdg-pet-ct-the-definite-resource-to-detect-the-recurrence-on-high-risk-thyroid-cancer-patients/>. ISSN 2359-3997.